Aspirin and sulfinpyrazone in threatened stroke

Completed

Phase N/A Results

Summary of Purpose

To determine whether aspirin or sulfinpyrazone, singly or in combination, influence the subsequent occurrence of continuing transient ischemic attacks, stroke or death.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 March 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Medical Research Council of Canada

Trial Design

Double-blind, randomized, stratified trial of 585 patients at 24 Canadian centers.

Contacts

Not available